Zimmer Biomet HLDS CVR
13F holders, Q1 2026 (March 31)1holders −1
0new positions
1sold out
$0.00avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Zimmer Biomet HLDS CVR in their 13F filings, down 1 from Q4 2025. 0 opened new positions and 1 sold out. The largest holder was Rhumbline Advisers ($0).
- Company
- Zimmer Biomet HLDS CVR
- CUSIP
- 609CVR022
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 1,028 shares sold, net −1,028 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Rhumbline Advisers | 0.00% | Reduce -0.8% | 67,326 | $0 |
"% of holder's portfolio" is ZIMMER BIOMET HLDS CVR's weight in each manager's 13F, not the share of Zimmer Biomet HLDS CVR the manager owns.